DNAprint Genomics (DNAG)

[frogdreaming]

gunnabe,

Allow me to interject a viewpoint into the discussion legitimately (not just vicariously as an accused multi-alias. lol)

>>"is the Dutchess commitment at a 4% discount MORE of a POSITIVE or a NEGATIVE indicator of what they see for DNAP's future?"

The premise here, being the discount is fairly small as compared to the 'normal' discount afforded to venture capitalists, and so there must be some other incentive drawing Durchess into the deal.

That is a fair assessment, but only if we base it on the assumption that Dutchess is inhabiting the role of a venture capitalist in support of DNAP management's master plan. If Dutchess is playing another role then the 'positive' premise becomes a question mark..

For example if Dutchess, instead of being a source of financing in support of DNAP's master plan, is in fact representing themselves in a major acquisition, then the indicator is not nearly so positive.

Under normal circumstances when an entity moves to obtain a significant share in a company they are forced to pay some premium to the open market share price. In this case Dutchess is getting a MINIMUM of 30% of DNAP, (which qualifies as a 'significant' share)yet they are not only avoiding a premium but they are getting a DISCOUNT.

If an entity such as Dutchess is being allowed to become a major part of the ownership structure of DNAP without paying a premium AND without being required to obtain their shares on the open market AND being granted a discount, then I suggest that it is a 'negative' indicator.

best regards,
frog